Synergistic interaction of amphotericin B and betulinic acid against clinically important fungi: evidence from in vitro and in silico techniques
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.03333-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Bence Rafael und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Amphotericin B, Antifungal Agents, Triterpenes, Fungi. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eötvös Loránd Research Network (ELKH), Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (NKFI).
Abstract (Originalsprache)
Betulinic acid (BA), in combined application with amphotericin B, shows a synergistic effect against Candida , Aspergillus , Scedosporium , Fusarium , and Mucorales fungi at a concentration as low as 0.125 µg/mL. Amphotericin B showed slightly higher affinity towards BA than toward ergosterol, according to our in silico molecular docking results, explaining the observed Eagle effect. Moreover, it can bind both molecules simultaneously, suggesting the possibility of the formation of mixed pores, thus increasing the membrane-disrupting activity. IMPORTANCE The rising incidence of invasive fungal infections, coupled with the emergence of antifungal resistance, presents a significant challenge in clinical settings. The inherent resistance of certain fungi to conventional antifungal agents, alongside the limitations posed by side effects and drug interactions, necessitates the exploration of alternative therapeutic strategies. This study highlights the potential of combining amphotericin B (AmB) with betulinic acid (BA) to enhance antifungal efficacy against clinically relevant pathogens, including Candida albicans and Aspergillus fumigatus , as well as mucormycosis-causing fungi. The results demonstrate the synergistic interactions between AmB and BA, which effectively inhibited fungal growth at lower concentrations and are within reported serum levels. In silico molecular docking studies further support the hypothesis that BA may facilitate AmB’s mechanism of action, potentially leading to increased pore formation in fungal membranes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.
- HUN-REN-SZTE Fungal Pathomechanisms Research Group, University of Szeged, Szeged, Hungary.
ORCID-Profile: Tamás Papp
Förderung
- Eötvös Loránd Research Network (ELKH)
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (NKFI)
Zitieren
APA
Rafael, B., Homa, M., Szebenyi, C., Vágvölgyi, C., Tyagi, C., & Papp, T. (2025). Synergistic interaction of amphotericin B and betulinic acid against clinically important fungi: evidence from in vitro and in silico techniques. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03333-24
Vancouver
Rafael B, Homa M, Szebenyi C, Vágvölgyi C, Tyagi C, Papp T. Synergistic interaction of amphotericin B and betulinic acid against clinically important fungi: evidence from in vitro and in silico techniques. Microbiology Spectrum. 2025. doi:10.1128/spectrum.03333-24
BibTeX
@article{Rafael2025,
author = {Rafael, Bence and Homa, Mónika and Szebenyi, Csilla and Vágvölgyi, Csaba and Tyagi, Chetna and Papp, Tamás},
title = {Synergistic interaction of amphotericin B and betulinic acid against clinically important fungi: evidence from in vitro and in silico techniques},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.03333-24}
}
EUVIMED